Brochures & spec sheets
Portable At-Home Hydrogen and Methane Testing: The OMED Health Breath Analyzer
Hydrogen and methane breath tests (HMBTs) are commonly used to diagnose various digestive disorders, such as small intestinal bacterial overgrowth (SIBO) and lactose intolerance. The North American Consensus Guidelines provide a standardized process for the optimal interpretation of HMBTs and were informed by experimental work and expert opinion by a consortium of specialists.
ViewDiscover how Breath Biopsy can empower your infectious disease research
ViewThe Role of Breathomics in Respiratory Disease Research
ViewBreath Analysis – A Tool for Investigating Liver Disease and other Metabolic Conditions
Breath biomarkers could lead to non-invasive detection and monitoring for liver disease, diabetes, kidney disease, heart failure, and other cardiovascular and metabolic diseases (CVMD).
ViewThe Volatile Metabolites of the Microbiome
The microbiome is responsible for a plethora of biological functions important to human health. Volatile metabolites are produced by the microbiome and are quantifiable using Breath Biopsy®. Measuring these metabolites in exhaled breath is a non-invasive method for investigating and monitoring dysbiosis in real-time and is compatible with high-frequency serial sampling to understand dynamic longitudinal changes in the microbiome.
ViewNon-invasive Functional Assessment of the Microbiome from Exhaled Breath
ViewGastrointestinal Health Breath Testing Solutions
Owlstone Medical provides a portfolio of breath-based products to facilitate understanding of microbiome function in human health.
ViewDiscover how Breath Biopsy® can empower your microbiome research
Find out why we use breath, what can be analyzed in breath, what data we have and how Owlstone Medical can help with microbiome research.
ViewIntroducing the Breath Biopsy® VOC Atlas
The VOC Atlas provides a comprehensive and growing catalog of VOCs (volatile organic compounds) confirmed to be present in exhaled human breath. This database acts as a resource to support clinical trial design, to speed up the development of breath VOC biomarkers by providing comparison data, and to enable development of new technologies for analyzing key molecules (e.g. home based collection/analysis methods).
ViewDiagnosis of Clostridioides Difficile Infection Using Breath Analysis
Volatile organic compounds (VOCs) produced as a consequence of Clostridioides Difficile infection (CDI) could act as a non-invasive and on-demand means of diagnosis.
View